The effectiveness of nirmatrelvir/ritonavir regimen in hospitalized renal transplant patients with prolonged COVID-19 infection: a multicenter clinical experience - Zhang, Huanxi; Wu, Wenrui; Zheng, Yitao; Fu, Qian; Chen, Peisong; Li, Jianyi; Wu, Zixuan; Gu, Jincui; Li, Jun; Liu, Longshan; Wu, Chenglin; Long, Sizhe; et al. (Renal failure, 2024)
Keywords: Adult; Aged; Antimetabolites; Antiviral Agents - administration & dosage; Antiviral Agents - therapeutic use; Calcineurin inhibitors; Corticosteroids; COVID-19; COVID-19 - complications; COVID-19 - mortality; COVID-19 Drug Treatment; Dialysis; Drug Combinations; efficacy; Female; Hospitalization - statistics & numerical data; Humans; Immunosuppressive agents; Immunosuppressive Agents - administration & dosage; Immunosuppressive Agents - adverse effects; Immunosuppressive Agents - therapeutic use; Intravenous administration; Kidney Transplantation; Lopinavir - administration & dosage; Lopinavir - therapeutic use; Male; Mechanical ventilation; Middle Aged; Mortality; Nirmatrelvir/ritonavir; Patients; Retrospective Studies; Ritonavir; Ritonavir - administration & dosage; Ritonavir - therapeutic use; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Steroids; Transplant Recipients - statistics & numerical data; Transplantation; Treatment Outcome; COVID-19; SARS-CoV-2; Nirmatrelvir/ritonavir; efficacy; kidney transplantation